Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Neurobiol Aging. 2009 Sep 20;32(8):1435–1442. doi: 10.1016/j.neurobiolaging.2009.08.013

Fig. 4.

Fig. 4

SELDI TOF MS revealed a decrease in the levels of exosomal Aβ and β-CTF mediated by expression of PS2 mutations. (A-B) SELDI TOF MS using 4G8 antibody revealed the presence of Aβ1-40 peptide (m/z = 4235) (A) and β-CTF (m/z = 11320) in exosomes (B). PS2 mutations reduced the levels of both Aβ1-40 and β-CTF. (PS2 M239I/PS2 T122R vs. PS2 wt, p < 0.01, Student’s t-test).